Andrew E. Sloan

Andrew E. Sloan, MD is a Professor and Vice Chairman of Neurosurgery at Case Western Reserve University School of Medicine. He holds the Peter D. Cristal Chair of Neurosurgical Oncology and directs the Brain Tumor and Neuro-Oncology Center at University Hospitals Cleveland Medical Center. His clinical roles include Senior Staff Neurosurgeon across multiple cancer centers.

Dr. Sloan earned his Doctor of Medicine from Harvard Medical School (1990), followed by neurosurgical residency at UCLA and fellowship at MD Anderson Cancer Center. His research focuses on brain tumor biology, immunotherapy, and advanced neurosurgical techniques.

His publications (2013-2015) explore glioblastoma stem cells, stereotactic radiosurgery, and molecular subtyping of brain tumors. Key contributions include clinical trials for NeuroBlate System and HSPPC-96 immunotherapy. He leads translational research initiatives through the Center of Excellence for Translational Neuro-Oncology.

Professional roles include directorships in neuro-oncology programs and advisory roles for clinical trials. His work bridges surgical innovation with genomic research to improve brain tumor treatment outcomes.